ADUS Stock Overview
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Addus HomeCare Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$86.18|
|52 Week High||US$108.11|
|52 Week Low||US$68.57|
|1 Month Change||0.27%|
|3 Month Change||5.70%|
|1 Year Change||-2.14%|
|3 Year Change||14.98%|
|5 Year Change||131.67%|
|Change since IPO||915.08%|
Recent News & Updates
Addus HomeCare Corporation's (NASDAQ:ADUS) Intrinsic Value Is Potentially 82% Above Its Share Price
How far off is Addus HomeCare Corporation ( NASDAQ:ADUS ) from its intrinsic value? Using the most recent financial...
Be Wary Of Addus HomeCare (NASDAQ:ADUS) And Its Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
|ADUS||US Healthcare||US Market|
Return vs Industry: ADUS underperformed the US Healthcare industry which returned 2.8% over the past year.
Return vs Market: ADUS exceeded the US Market which returned -20.5% over the past year.
|ADUS Average Weekly Movement||5.8%|
|Healthcare Industry Average Movement||9.2%|
|Market Average Movement||8.0%|
|10% most volatile stocks in US Market||16.6%|
|10% least volatile stocks in US Market||3.1%|
Stable Share Price: ADUS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: ADUS's weekly volatility (6%) has been stable over the past year.
About the Company
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Addus HomeCare Fundamentals Summary
|ADUS fundamental statistics|
Is ADUS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ADUS income statement (TTM)|
|Cost of Revenue||US$605.60m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||2.81|
|Net Profit Margin||5.05%|
How did ADUS perform over the long term?See historical performance and comparison
Is ADUS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ADUS?
Other financial metrics that can be useful for relative valuation.
|What is ADUS's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does ADUS's PE Ratio compare to its peers?
|ADUS PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: ADUS is good value based on its Price-To-Earnings Ratio (30.7x) compared to the peer average (39x).
Price to Earnings Ratio vs Industry
How does ADUS's PE Ratio compare vs other companies in the U.S. Healthcare Industry?
Price-To-Earnings vs Industry: ADUS is expensive based on its Price-To-Earnings Ratio (30.7x) compared to the US Healthcare industry average (18.9x)
Price to Earnings Ratio vs Fair Ratio
What is ADUS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||30.7x|
|Fair PE Ratio||27.1x|
Price-To-Earnings vs Fair Ratio: ADUS is expensive based on its Price-To-Earnings Ratio (30.7x) compared to the estimated Fair Price-To-Earnings Ratio (27.1x).
Share Price vs Fair Value
What is the Fair Price of ADUS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ADUS ($86.18) is trading below our estimate of fair value ($143.14)
Significantly Below Fair Value: ADUS is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: ADUS is poor value based on its PEG Ratio (2x)
Discover undervalued companies
How is Addus HomeCare forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ADUS's forecast earnings growth (15.7% per year) is above the savings rate (1.9%).
Earnings vs Market: ADUS's earnings (15.7% per year) are forecast to grow faster than the US market (13.9% per year).
High Growth Earnings: ADUS's earnings are forecast to grow, but not significantly.
Revenue vs Market: ADUS's revenue (7.3% per year) is forecast to grow slower than the US market (8.3% per year).
High Growth Revenue: ADUS's revenue (7.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ADUS's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Addus HomeCare performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ADUS has high quality earnings.
Growing Profit Margin: ADUS's current net profit margins (5%) are higher than last year (4.3%).
Past Earnings Growth Analysis
Earnings Trend: ADUS's earnings have grown significantly by 26.1% per year over the past 5 years.
Accelerating Growth: ADUS's earnings growth over the past year (34%) exceeds its 5-year average (26.1% per year).
Earnings vs Industry: ADUS earnings growth over the past year (34%) exceeded the Healthcare industry 9.6%.
Return on Equity
High ROE: ADUS's Return on Equity (7.6%) is considered low.
Discover strong past performing companies
How is Addus HomeCare's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: ADUS's short term assets ($276.2M) exceed its short term liabilities ($104.4M).
Long Term Liabilities: ADUS's short term assets ($276.2M) do not cover its long term liabilities ($297.1M).
Debt to Equity History and Analysis
Debt Level: ADUS's net debt to equity ratio (22.4%) is considered satisfactory.
Reducing Debt: ADUS's debt to equity ratio has increased from 13.7% to 43.7% over the past 5 years.
Debt Coverage: ADUS's debt is well covered by operating cash flow (24.9%).
Interest Coverage: ADUS's interest payments on its debt are well covered by EBIT (12.1x coverage).
Discover healthy companies
What is Addus HomeCare current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ADUS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ADUS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ADUS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ADUS's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ADUS has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
R. Allison (65 yo)
Mr. R. Dirk Allison serves as Chairman of the Board at Addus HomeCare Corporation since March 2021 and its Chief Executive Officer since January 2016. Mr. Allison has been the Chief Executive Officer and P...
CEO Compensation Analysis
Compensation vs Market: R.'s total compensation ($USD3.44M) is below average for companies of similar size in the US market ($USD5.50M).
Compensation vs Earnings: R.'s compensation has been consistent with company performance over the past year.
Experienced Management: ADUS's management team is considered experienced (4.4 years average tenure).
Experienced Board: ADUS's board of directors are considered experienced (5.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ADUS insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Addus HomeCare Corporation's employee growth, exchange listings and data sources
- Name: Addus HomeCare Corporation
- Ticker: ADUS
- Exchange: NasdaqGS
- Founded: 1979
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$1.300b
- Shares outstanding: 15.91m
- Website: https://addus.com
Number of Employees
- Addus HomeCare Corporation
- 6303 Cowboys Way
- Suite 600
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/24 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.